Trial Profile
Effects of intraocular pressure reduction in combined use with ripasudil and brimonidine, or pilocarpine in healthy adult volunteers.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Apr 2018
Price :
$35
*
At a glance
- Drugs Brimonidine (Primary) ; Pilocarpine (Primary) ; Ripasudil (Primary)
- Indications Glaucoma
- Focus Therapeutic Use
- 01 Apr 2018 Status changed from active, no longer recruiting to completed.
- 21 Apr 2017 New trial record